Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.

Nonmainstream doctors and health leaders are wielding serious muscle in shaping the incoming administration’s health policies ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

The Biden administration is proposing a rule that would require the US government to cover obesity drugs for millions of ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...

In one of the Biden administration’s final health policy pushes, the White House unveiled a proposal to ensure Medicare and Medicaid coverage for obesity drugs.

Should employers, patients or insurers cover the $411 billion annual cost for GLP-1 drugs? U.S. healthcare industry grapples with this question as demand grows.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden proposes Medicaid, Medicare cover ...